RADNOR, Pa., Nov. 04, 2024 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the third quarter ended September 30, 2024, after the financial markets close on Monday, November 11, 2024.
| Monday, November 11th @ 4:30 p.m. ET | |
| Domestic: | 1-877-407-9127 |
| International: | 1-201-689-8574 |
| Webcast: | Link |
A live webcast of the conference call may also be found on the “News & Events” page in the Investor Relations section of the Mineralys Therapeutics website.
About Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, CKD and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that Mineralys Therapeutics is developing for cardiorenal conditions affected by dysregulated aldosterone, including hypertension and CKD. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn and Twitter.
Contact:
Investor Relations
investorrelations@mineralystx.com
Media Relations
Tom Weible
Elixir Health Public Relations
Phone: (1) 515-707-9678
Email: tweible@elixirhealthpr.com
According to Pixalate's research, 'My FitnessPal' ranked at the top on both Google Play Store…
According to Pixalate's research, ‘Gangstar Vegas: World of Crime’ on Google Play Store generated an…
According to Pixalate's research, ‘Pro Des Mots’ led on Apple App Store in France, ‘SimCity’…
IBTA Robbins LLP is Investigating Allegations that Ibotta, Inc. (IBTA) Misled Investors in Connection with…
Santa Clara, April 21, 2025 (GLOBE NEWSWIRE) -- Santa Clara, California - The global Edge…
According to Pixalate's research, the app ‘My Fitness Pal’ in Canada generated an estimated $230K…
This website uses cookies.